<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Widespread Itch (Pruritus) – Primary Care Quick Reference</title>
  <style>
    :root{
      --bg: #f7fafc;           /* soft light gray */
      --panel: #ffffff;        /* card background */
      --ink: #1f2937;          /* slate-800 */
      --muted: #4b5563;        /* slate-600 */
      --accent: #2563eb;       /* blue-600 */
      --accent-2: #22c55e;     /* green-500 */
      --accent-3: #f59e0b;     /* amber-500 */
      --border: #e5e7eb;       /* gray-200 */
      --chip: #eef2ff;         /* indigo-50 */
      --chip-text: #3730a3;    /* indigo-800 */
      --shadow: 0 10px 20px rgba(2, 8, 23, .06), 0 2px 6px rgba(2,8,23,.04);
    }

    html, body { background: var(--bg); color: var(--ink); margin: 0; font-family: system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji"; }
    .container { max-width: 1024px; margin: 0 auto; padding: 24px; }

    /* Header */
    header.hero { background: linear-gradient(180deg, #ffffff 0%, #f8fbff 100%); border: 1px solid var(--border); border-radius: 16px; padding: 28px 24px; box-shadow: var(--shadow); }
    .title { display:flex; gap:16px; align-items:center; flex-wrap:wrap; }
    .title h1 { font-size: clamp(22px, 2.2vw + 10px, 34px); line-height: 1.15; margin: 0; letter-spacing: -0.02em; }
    .badge { display:inline-flex; gap:8px; align-items:center; padding: 6px 10px; border-radius: 999px; background: var(--chip); color: var(--chip-text); font-weight: 600; font-size: 12px; border: 1px solid #e0e7ff; }
    .meta { display:flex; gap:14px; margin-top: 10px; color: var(--muted); font-size: 14px; flex-wrap:wrap; }

    /* Layout */
    .grid { display:grid; grid-template-columns: 1.1fr 1fr; gap: 20px; margin-top: 20px; }
    @media (max-width: 900px){ .grid { grid-template-columns: 1fr; } }

    /* Cards */
    .card { background: var(--panel); border:1px solid var(--border); border-radius: 14px; padding: 18px 18px 16px; box-shadow: var(--shadow); }
    .card h2 { margin: 0 0 12px; font-size: 18px; letter-spacing: -0.01em; }
    .card h3 { margin: 12px 0 8px; font-size: 15px; color: var(--muted); }
    .card p { margin: 8px 0; }
    .list { margin: 8px 0 0; padding-left: 20px; }
    .list li { margin: 6px 0; }

    /* Pills */
    .pills { display:flex; flex-wrap:wrap; gap: 8px; margin-top: 10px; }
    .pill { background:#f0f9ff; color:#075985; border:1px solid #e0f2fe; padding:6px 10px; border-radius: 999px; font-size: 12px; font-weight:600; }

    /* Algorithm flow */
    .flow { position: relative; display:grid; gap:14px; }
    .step { position:relative; border-left: 4px solid var(--accent); background: #fff; padding: 12px 12px 12px 14px; border-radius: 10px; border:1px solid var(--border); }
    .step .kicker { font-weight:700; font-size: 12px; letter-spacing: .08em; text-transform: uppercase; color: var(--accent); }
    .step .heading { font-size: 16px; font-weight: 700; margin: 4px 0 6px; }
    .step ul { margin: 0; padding-left: 20px; }

    /* Dosing table */
    table { width:100%; border-collapse: collapse; font-size: 14px; }
    th, td { border-bottom: 1px solid var(--border); padding: 10px 8px; text-align:left; vertical-align:top; }
    th { background:#f9fafb; font-weight:700; }
    .note { font-size: 12px; color: var(--muted); }

    /* Callouts */
    .callout { display:flex; gap:12px; align-items:flex-start; border:1px solid var(--border); background:#fff7ed; border-left: 4px solid var(--accent-3); padding: 12px; border-radius: 12px; }
    .success { background:#f0fdf4; border-left-color: var(--accent-2); }

    /* Footer */
    footer { margin-top: 18px; color: var(--muted); font-size: 12px; text-align:center; }

    /* Print (A4 one-pager) */
    @media print {
      :root{ --bg:#ffffff; }
      .container { max-width: none; padding: 12mm; }
      header.hero { box-shadow: none; }
      .card { box-shadow: none; }
      .grid { grid-template-columns: 1fr 1fr; gap: 10mm; }
      a[href]:after{ content:""; } /* remove link URLs */
    }
  </style>
</head>
<body>
  <div class="container">
    <header class="hero">
      <div class="title">
        <svg width="44" height="44" viewBox="0 0 24 24" fill="none" aria-hidden="true">
          <circle cx="12" cy="12" r="10" stroke="#2563eb" stroke-width="2" fill="#eff6ff" />
          <path d="M12 7v6" stroke="#2563eb" stroke-width="2" stroke-linecap="round"/>
          <circle cx="12" cy="16.5" r="1" fill="#2563eb"/>
        </svg>
        <h1>Widespread Itch (Pruritus) — Primary Care Quick Reference</h1>
        <span class="badge" title="Applies to age ≥12 years">
          <svg width="14" height="14" viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M5 12l4 4L19 6" stroke="#4f46e5" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
          Age ≥ 12 yrs
        </span>
      </div>
      <div class="meta">
        <span>Designed for rapid in‑consultation use.</span>
        <span>Based on NICE CKS: Itch – widespread (Jan 2024).</span>
        <span>Focus: no primary skin disease/rash.</span>
      </div>
      <div class="pills" aria-label="Quick tags">
        <span class="pill">Assessment</span>
        <span class="pill">Investigations</span>
        <span class="pill">Stepwise Management</span>
        <span class="pill">First‑line Measures</span>
        <span class="pill">Dosing</span>
        <span class="pill">Referral</span>
      </div>
    </header>

    <section class="grid">
      <!-- Left column -->
      <div class="card">
        <h2>Algorithm — Fast Decisions</h2>
        <div class="flow">
          <div class="step">
            <div class="kicker">Step 1</div>
            <div class="heading">Initial Assessment</div>
            <ul>
              <li><strong>History:</strong> onset &gt;6wks (chronic), nocturnal itch, triggers (heat/water/stress/drugs/alcohol/travel), impact (QoL), contacts (scabies), family hx.</li>
              <li><strong>Red flags:</strong> fatigue, fever, night sweats, weight loss.</li>
              <li><strong>Examination:</strong> exclude dermatoses/infestation; excoriations; jaundice/anaemia/uraemia/thyroid signs; nodes / hepatosplenomegaly.</li>
            </ul>
          </div>

          <div class="step">
            <div class="kicker">Step 2</div>
            <div class="heading">Investigations (if no primary skin disease)</div>
            <ul>
              <li>FBC &amp; film, ESR/CRP, LFTs, U&amp;E, iron/ferritin.</li>
              <li>Consider: TFTs, HbA1c, bone chemistry, HIV, Hep B/C, CXR.</li>
              <li>Re‑evaluate periodically — itch can precede systemic disease.</li>
            </ul>
          </div>

          <div class="step">
            <div class="kicker">Step 3</div>
            <div class="heading">Determine Pathway</div>
            <ul>
              <li><strong>Known/suspected cause</strong> → treat underlying cause ± refer (renal, hepatic, endocrine, haematological, malignancy, neuropathic, psychogenic).</li>
              <li><strong>Unknown cause</strong> → symptom control + supportive care.</li>
            </ul>
          </div>

          <div class="step">
            <div class="kicker">Step 4</div>
            <div class="heading">First‑Line Measures (All)</div>
            <ul>
              <li><strong>Emollients:</strong> soap substitute + regular moisturiser; consider menthol 0.5–1% in aqueous cream if inadequate relief.</li>
              <li><strong>Self‑care:</strong> short lukewarm bathing (&lt;20 min), avoid harsh soaps/perfumes, pat dry, trim nails, cool indoor air/humidify, loose cotton/silk, avoid alcohol/caffeine/spicy foods.</li>
              <li>Address sleep disturbance, anxiety/depression; manage secondary infection/excoriations.</li>
            </ul>
          </div>

          <div class="step">
            <div class="kicker">Step 5</div>
            <div class="heading">Pharmacological Symptom Relief</div>
            <ul>
              <li><strong>Non‑sedating antihistamine</strong> (off‑label for itch) trial 2–3 weeks: Cetirizine 10 mg OD; Loratadine 10 mg OD; Fexofenadine 180 mg OD.</li>
              <li><strong>Nocturnal itch</strong> (short‑term 2–3 weeks): Hydroxyzine 25 mg nocte (adults); Chlorphenamine 4 mg nocte.</li>
              <li class="note">Not routinely recommended in primary care: topical anaesthetics/antihistamines/capsaicin/corticosteroids/calcineurin inhibitors/doxepin; oral corticosteroids.</li>
            </ul>
          </div>

          <div class="step">
            <div class="kicker">Step 6</div>
            <div class="heading">Escalation / Referral</div>
            <ul>
              <li>Persistent symptoms despite above, or concerning systemic features → refer (Dermatology ± relevant specialty).</li>
              <li>Dermatology options may include: SSRIs, mirtazapine, TCAs, gabapentin/pregabalin, immunosuppressants, phototherapy, biopsy as indicated.</li>
            </ul>
          </div>
        </div>

        <div class="callout" style="margin-top:12px;">
          <svg width="22" height="22" viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 9v4" stroke="#f59e0b" stroke-width="2" stroke-linecap="round"/><circle cx="12" cy="17" r="1" fill="#f59e0b"/><path d="M12 2L2 7v10l10 5 10-5V7L12 2z" stroke="#f59e0b" stroke-width="1.5" fill="none"/></svg>
          <div>
            <strong>Key reminders:</strong> Itch may <em>precede</em> other disease signs; re‑check if new systemic symptoms develop. Offer support for psychological distress. Treat secondary infection promptly.
          </div>
        </div>
      </div>

      <!-- Right column -->
      <div class="card">
        <h2>Antihistamine Dosing &amp; Safety (Quick View)</h2>
        <table aria-label="Dosing table">
          <thead>
            <tr>
              <th style="width:30%">Drug</th>
              <th>Typical dose</th>
              <th>Key cautions / interactions</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td><strong>Cetirizine</strong></td>
              <td>10 mg once daily (trial 2–3 weeks)</td>
              <td>
                Avoid in ESRD (eGFR &lt;15). If eGFR 30–59 → ½ dose; eGFR 15–29 → 5 mg every 48 h. Possible drowsiness; ↓ effect of betahistine.
              </td>
            </tr>
            <tr>
              <td><strong>Loratadine</strong></td>
              <td>10 mg once daily</td>
              <td>Severe hepatic impairment → alternate‑day dosing. Rare sedation; may ↓ betahistine effect.
              </td>
            </tr>
            <tr>
              <td><strong>Fexofenadine</strong></td>
              <td>180 mg once daily</td>
              <td>Few cautions. Interactions: antacids (separate by 2 h), rifampicin ↓ levels; others possible (e.g., MAOI, leflunomide, mirabegron).
              </td>
            </tr>
            <tr>
              <td><strong>Hydroxyzine</strong> <span class="note">(nocte)</span></td>
              <td>Adults: 25 mg at night (short‑term)</td>
              <td>
                <strong>Avoid</strong> with QT‑prolongation risks/drugs. Many cautions (hepatic/renal impairment, glaucoma, urinary retention, etc.). Multiple interactions; CNS depressants ↑ sedation.
              </td>
            </tr>
            <tr>
              <td><strong>Chlorphenamine</strong> <span class="note">(nocte)</span></td>
              <td>4 mg at night (short‑term)</td>
              <td>Anticholinergic &amp; sedative effects; caution in hepatic impairment, glaucoma, urinary retention; many CNS‑depressant interactions.
              </td>
            </tr>
          </tbody>
        </table>

        <h3 style="margin-top:14px">Non‑pharmacological Essentials</h3>
        <ul class="list">
          <li>Emollient as wash &amp; moisturiser; consider menthol 0.5–1% if poor relief.</li>
          <li>Short lukewarm bathing; avoid bubble baths/high‑pH soaps/perfumes.</li>
          <li>Pat dry; keep nails short; cool, humidified rooms; loose cotton/silk clothing.</li>
          <li>Avoid alcohol, caffeine, spicy food when flaring.</li>
        </ul>

        <div class="success callout" style="margin-top:12px;">
          <svg width="22" height="22" viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M5 13l4 4L19 7" stroke="#16a34a" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
          <div>
            <strong>When to Refer:</strong> persistent itch despite stepwise care; suspected systemic disease; psychogenic causes not manageable in primary care; need for biopsy or advanced therapies.
          </div>
        </div>

        <h3 style="margin-top:14px">Avoid (Primary Care)</h3>
        <ul class="list">
          <li>Topical anaesthetics, topical antihistamines, capsaicin, corticosteroids, calcineurin inhibitors, doxepin.</li>
          <li>Oral corticosteroids for itch relief.</li>
        </ul>
      </div>
    </section>

    <footer>
      © 2025 · Quick reference designed for busy consultations · This page presents a condensed summary aligned with NICE CKS Itch – widespread (Jan 2024). Use clinical judgment and local formulary.
    </footer>
  </div>
</body>
</html>
